Evidence map›Paper›PMID 39364123›Full record

ArticleBioscience of microbiota, food and health2024

α-ketoglutarate produced by lactic acid bacteria inhibits hyaluronidase activity.

Taiki Sato, Takahiro Matsuda, Keisuke Tagawa, Shuichi Segawa

Abstract read
In one paragraph

Article in Bioscience of microbiota, food and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taiki SatoDevelopment Laboratories, Nissin York Co., Ltd., 272 Kamimurakimi, Hanyu, Saitama 348-8549, Japan.
Takahiro MatsudaResearch Institute of Food Safety, Nissin Foods Holdings Co., Ltd., 2100 Tobuki-cho, Hachioji-shi, Tokyo 192-0001, Japan.
Keisuke TagawaDevelopment Laboratories, Nissin York Co., Ltd., 272 Kamimurakimi, Hanyu, Saitama 348-8549, Japan.
Shuichi SegawaDevelopment Laboratories, Nissin York Co., Ltd., 272 Kamimurakimi, Hanyu, Saitama 348-8549, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Japan, the growing interest in anti-aging skin care is associated with the unprecedented aging society. Skin aging can be attributed to various factors, including the activation of hyaluronidase enzyme in subcutaneous tissues exposed to ultraviolet radiation. This enzyme breaks down hyaluronic acid, leading to skin sagging. Therefore, hyaluronidase inhibitors can effectively prevent skin aging. Previously, food components have been actively explored to search for hyaluronidase inhibitors considering the high safety of these materials. Although lactic acid bacteria (LAB)-fermented foods inhibit this enzyme, their active compounds responsible for hyaluronidase inhibition remain unknown. Thus, in this study, we aimed to explore the mechanism underlying the LAB-mediated inhibition of hyaluronidase activity. Supernatants of a LAB-fermented milk-based beverage were subjected to a hyaluronidase inhibition assay, followed by purification and separation using hydrophobic adsorbents and high-performance liquid chromatography, respectively. Subsequently, liquid chromatograph time-of-flight mass analysis was performed, revealing α-ketoglutarate (AKG) as the inhibitor of this enzyme. The half-maximal inhibitory concentration (IC

Indexed as

anti-agingfermented milkhyaluronidaseLactobacillusskinStreptococcusα-ketoglutarate

Identifiers

PMID39364123
PMCPMC11444863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.